• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Naturally Splendid Closes Initial Tranche for $783,585

    Matthew Spizziri
    Aug. 23, 2016 10:40AM PST
    Biotech Investing
    Biotech Investing

    VANCOUVER, British Columbia, Aug. 23, 2016 (GLOBE NEWSWIRE) — Naturally Splendid (TSXV:NSP) is pleased to announce that it has closed the initial tranche of its previously announced private placement financing by issuing a total of [2,902,168] units (the “Units”) for gross proceeds of [$783,585].

    VANCOUVER, British Columbia, Aug. 23, 2016 (GLOBE NEWSWIRE) — Naturally Splendid (TSXV:NSP) is pleased to announce that it has closed the initial tranche of its previously announced private placement financing by issuing a total of [2,902,168] units (the “Units”) for gross proceeds of [$783,585].

    Each Unit is comprised of one common share of Naturally Splendid and one-half of one common share purchase warrant (“Warrant”), with each whole Warrant entitling the holder to purchase one additional common share at $0.35 per share for a period of two years from the date of the issue.  Naturally Splendid will have the right to accelerate the expiry date of the Warrants if, at any time, the average closing price of Naturally Splendid’s common shares is equal to or greater than $0.45 for 10 consecutive trading days.  In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after Naturally Splendid issues a news release announcing that it has elected to exercise this acceleration right.

    In connection with the initial tranche of the financing, Naturally Splendid paid finders a cash commission totaling $65,677 and issued a total of 135,150 finder’s warrants.  Each finder’s warrant is on the same terms as the Warrants.

    The securities issued under the financing will be subject to a hold period expiring on December 23, 2016 pursuant to applicable securities laws and the rules of the TSX Venture Exchange.

    Proceeds of the financing will be used for product development and working capital and corporate purposes.

    Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

    NSP:CA
    private placement
    The Conversation (0)

    Go Deeper

    AI Powered

    NexGen Closes US$110 Million Strategic Convertible Debenture Financing

    CORRECTION: Naturally Splendid Reports Second Quarter Results for 2022

    CORRECTION: Naturally Splendid Reports Second Quarter Results for 2022

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×